Dr. Frank Vandeputte
ActiveDr. Frank Vandeputte has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €327k and a net result of €75k. Equity is growing by ~17.5% per year across the filed fiscal years. Its solvency ranks better than 69% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability92▲+11
Solvency100=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 4.25 against 10.17 in 2023; short-term debt: 18.4% and cash: 56.2% of total assets), and 18.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
81.6%
Return on assets
18.7%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
56 d late
2022
60 d late
2021
117 d late
2020
117 d late
2019
88 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€327k▲ 14.9%
2023 · €284k
2018: €80k
2019: €108k
2020: €186k
2021: €243k
2022: €275k
2023: €284k
2018 → 2024
Total assets
€400k▲ 31.6%
2023 · €304k
2018: €130k
2019: €138k
2020: €240k
2021: €301k
2022: €327k
2023: €304k
2018 → 2024
Net result
€75k▲ 149%
2023 · €30k
2018: €33k
2019: €27k
2020: €78k
2021: €57k
2022: €46k
2023: €30k
2018 → 2024
Working capital
€239k▲ 31.7%
2023 · €181k
2018: €39k
2019: €55k
2020: €120k
2021: €164k
2022: €201k
2023: €181k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€186k-€243k▲ 30.5%€275k▲ 13.4%€284k▲ 3.3%€327k▲ 14.9%
Operating result€112k-€81k▼ 27.9%€70k▼ 12.6%€43k▼ 38.3%€107k▲ 145%
Net result€78k-€57k▼ 27.5%€46k▼ 18.6%€30k▼ 34.7%€75k▲ 149%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 145% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €400k
Fixed assets
€88k▼ 14.6%
Current assets
€312k▲ 55.3%
Equity and liabilities €400k
Equity
€327k▲ 14.9%
Debt
€73k▲ 272%
The debt ratio rises from 6.5% to 18.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€122k▲
2023 · €59k
Cash flow
€90k▲
2023 · €45k
Solvency
81.6%▼
2023 · 93.5%
Current ratio
4.25▼
2023 · 10.17
Quick ratio
4.25▼
2023 · 10.17
Debt / equity
0.22▲
2023 · 0.07
ROE
23.0%▲
2023 · 10.6%
ROA
18.7%▲
2023 · 9.9%
Interest coverage
113.53▲
2023 · 49.50
Debt
€73k▲
2023 · €20k
Debt ≤ 1 year
€73k▲
2023 · €20k
Income taxes
€31k▲
2023 · €13k
Staff costs
€22k▲
2023 · €19k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€304k€400k▲
Fixed assets21/28€103k€88k▼
Tangible fixed assets22/27€103k€88k▼
Land and buildings22€74k€66k▼
Plant, machinery and equipment23€29k€22k▼
Furniture and vehicles24€2-
Current assets29/58€201k€312k▲
Amounts receivable within one year40/41€41k€31k▼
Trade receivables40-€7k
Other amounts receivable41€41k€24k▼
Current investments50/53-€54k
Cash at bank and in hand54/58€155k€225k▲
Deferred charges and accrued income490/1€5k€2k▼
Equity and liabilities
Total equity and liabilities10/49€304k€400k▲
Equity10/15€284k€327k▲
Contributions10/11€6k€6k=
Reserves13€278k€321k▲
Distributable reserves133€278k€321k▲
Amounts payable17/49€20k€73k▲
Amounts payable within one year42/48€20k€73k▲
Trade debts44€6k€11k▲
Suppliers440/4€6k€11k▲
Taxes, remuneration and social security45€13k€29k▲
Taxes450/3€13k€29k▲
Other amounts payable47/48-€34k
Income statement
Code20232024
Remuneration, social security and pensions62€19k€22k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€15k▼
Other operating charges640/8€2k€1k▼
Gross operating margin9900€79k€144k▲
Operating profit (loss)9901€43k€107k▲
Financial income75/76B€1k€575▼
Recurring financial income75€1k€575▼
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€43k€106k▲
Income taxes67/77€13k€31k▲
Profit (loss) for the period9904€30k€75k▲
Profit (loss) for the period to be appropriated9905€30k€75k▲
Appropriation of the result
Profit (loss) to be appropriated9906€30k€75k▲
Transfer from equity791/2€8k€33k▲
Transfer to equity691/2€30k€75k▲
To other reserves6921€30k€75k▲
Profit to be distributed694/7€8k€33k▲
Return on contributions (dividend)694€8k€33k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
25-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 56 days late
2023
31-12
Financial
Liquidity doublescurrent ratio 10.17
Current ratio from 4.85 to 10.17; short-term debt falls from €52k to €20k.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
25-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 117 days late
2021
31-12
Financial
Equity above €200kEq €243k ▲30.5%
4 profitable years in a row build equity to €243k.
25-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 117 days late
2020
31-12
Financial
Highest result since 2018net €78k ▲184%
Operating result €112k, net result €78k, both a record.
31-12
Financial
Equity above €150kEq €186k ▲72.4%
3 profitable years in a row build equity to €186k.
27-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 88 days late
2019
31-12
Financial
Weakest financial yearnet €27k ▼15.7%
Net result drops to €27k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €100kEq €108k ▲34.2%
2 profitable years in a row build equity to €108k.
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
17-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 17 days late
2016
27-09
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 58 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hove · 1 establishment unit since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Groenenborglei 342540 HoveGround area
478 m²
Building footprint
179 m²
Volume, LiDAR
1,187 m³
Parcel 11021A0036/00D007, Flanders · tallest building 7.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Frank Vandeputte
since 20072.160.267.303
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11021A0036/00D007 | Flanders | 478 m² | 1 · 179 m² | 7.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Heidi Debels, Plastische Chirurgie
BE 0772.523.737
Gent · Eq €327k
Dokter Sofie Portier
BE 0767.718.079
Wetteren · Eq €327k
DR. WIM DE BACKER
BE 0467.978.280
Schelle · Eq €326k
Dokter Beeckmans, sport- en controlearts, algemene geneeskunde
BE 0650.769.040
Mol · Eq €327k
Dr. PETER SCHOTTE
BE 0550.873.391
Bonheiden · Eq €327k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,181 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-12-2006
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86220Specialist medical practice
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.